Cargando…

A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China

BACKGROUND: Blood glucose excursion is an important component of the glycaemic burden, but there are no indexes that can directly reflect them. The aim was to evaluate the values and significance of serum 1,5-anhydroglucitol (1,5-AG) in people with type 2 diabetes mellitus in China and to elucidate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Y, Zhang, Y L, Wang, Y P, Lei, C H, Sun, Z L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2012
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510303/ https://www.ncbi.nlm.nih.gov/pubmed/22238204 http://dx.doi.org/10.1002/dmrr.2278

Ejemplares similares

1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
por: Seok, Hannah, et al.
Publicado: (2015)

Data for serum 1,5 anhydroglucitol concentration in different populations
por: Welter, Marciane, et al.
Publicado: (2018)

Value of serum 1,5-anhydroglucitol measurements in childhood obesity in the continuum of diabetes
por: Yoo, Ha Yeong, et al.
Publicado: (2015)

Continuous Glucose Monitoring for Evaluation of Glycemic Excursions after Gastric Bypass
por: Halperin, Florencia, et al.
Publicado: (2011)

Association between a biomarker of glucose spikes, 1,5-anhydroglucitol, and cancer mortality
por: Kira, Sakurako, et al.
Publicado: (2020)

Serum 1,5-anhydroglucitol when used with fasting plasma glucose improves the efficiency of diabetes screening in a Chinese population
por: Ying, Lingwen, et al.
Publicado: (2017)

Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality
por: Selvin, Elizabeth, et al.
Publicado: (2016)

Evaluation of Serum 1,5 Anhydroglucitol Levels as a Clinical Test to Differentiate Subtypes of Diabetes
por: Pal, Aparna, et al.
Publicado: (2010)

Minimizing Glucose Excursions (GEM) With Continuous Glucose Monitoring in Type 2 Diabetes: A Randomized Clinical Trial
por: Cox, Daniel J, et al.
Publicado: (2020)

Association of 1,5-Anhydroglucitol and 2-h Postprandial Blood Glucose in Type 2 Diabetic Patients
por: Stettler, Christoph, et al.
Publicado: (2008)

Continuous Glucose Monitoring in Adolescents With Obesity: Monitoring of Glucose Profiles, Glycemic Excursions, and Adherence to Time Restricted Eating Programs
por: Naguib, Monica N., et al.
Publicado: (2022)

1,5-Anhydroglucitol as a Marker of Acute Hyperglycemia in Cardiovascular Events
por: Migała, Marta, et al.
Publicado: (2022)

Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism
por: Li, Man, et al.
Publicado: (2017)

Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis
por: Tanaka, Kenji, et al.
Publicado: (2021)

CORRIGENDUM FOR “Minimizing Glucose Excursions (GEM) With Continuous Glucose Monitoring in Type 2 Diabetes: A Randomized Clinical Trial”
Publicado: (2020)

Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

Salivary 1,5-Anhydroglucitol and Vitamin Levels in Relation to Caries Risk in Children
por: Syed, Sadatullah, et al.
Publicado: (2019)

Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners
por: Peabody, John, et al.
Publicado: (2020)

Hyperglycaemic Hemichorea
por: Marques, Joana Silva, et al.
Publicado: (2018)

1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure
por: Zhang, Lingjian, et al.
Publicado: (2022)

Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance
por: Pramodkumar, Thyparambil Aravindakshan, et al.
Publicado: (2016)

Rare variants in SLC5A10 are associated with serum 1,5-anhydroglucitol (1,5-AG) in the Atherosclerosis Risk in Communities (ARIC) Study
por: Loomis, Stephanie J., et al.
Publicado: (2019)

Response to Letter by Seibold regarding “Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes”
por: Oliver, Nick, et al.
Publicado: (2020)

Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol
por: Lee, Ji-Eun
Publicado: (2015)

Measurement of 1,5-anhydroglucitol in blood and saliva: from non-targeted metabolomics to biochemical assay
por: Halama, Anna, et al.
Publicado: (2016)

Serum 1,5-Anhydroglucitol Concentrations Are a Reliable Index of Glycemic Control in Type 2 Diabetes With Mild or Moderate Renal Dysfunction
por: Kim, Won Jun, et al.
Publicado: (2012)

Largest Amplitude of Glycemic Excursion Calculating from Self-Monitoring Blood Glucose Predicted the Episodes of Nocturnal Asymptomatic Hypoglycemia Detecting by Continuous Glucose Monitoring in Outpatients with Type 2 Diabetes
por: Wang, Shoubi, et al.
Publicado: (2022)

Saliva 1,5-anhydroglucitol is associated with early-phase insulin secretion in Chinese patients with type 2 diabetes
por: Ying, Lingwen, et al.
Publicado: (2021)

Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome
por: Su, Gong, et al.
Publicado: (2020)

Salivary 1,5-Anhydroglucitol and its Correlation with Postprandial Hyperglycemia: Development and Validation of a Novel Assay
por: Kedarnath, Priyadarshini Subramaniam, et al.
Publicado: (2023)

The effect of basal–bolus therapy varies with baseline 1,5‐anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis
por: Heller, S., et al.
Publicado: (2018)

Effect of Eating Glutinous Brown Rice Twice a Day for 6 Weeks on Serum 1,5-Anhydroglucitol in Japanese Subjects without Diabetes
por: Nakayama, Taiga, et al.
Publicado: (2020)

Continuous Glucose Monitoring in the Hospital
por: Perez-Guzman, M. Citlalli, et al.
Publicado: (2021)

Repeated 3-minute stair climbing-descending exercise after a meal over 2 weeks increases serum 1,5-anhydroglucitol levels in people with type 2 diabetes
por: Honda, Hiroto, et al.
Publicado: (2017)

1,5-anhydroglucitol is a good predictor for the treatment effect of the Sodium-Glucose cotransporter 2 inhibitor in Japanese patients with type 2 diabetes mellitus
por: Usui, Masahiro, et al.
Publicado: (2020)

Nonlinear association of 1,5-anhydroglucitol with the prevalence and severity of coronary artery disease in chinese patients undergoing coronary angiography
por: Yang, Ruiyue, et al.
Publicado: (2022)

Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes
por: Shen, Yun, et al.
Publicado: (2020)

Hyperglycaemic index as a tool to assess glucose control: a retrospective study
por: Vogelzang, Mathijs, et al.
Publicado: (2004)

An Efficient Electrochemical Biosensor to Determine 1,5-Anhydroglucitol with Persimmon-Tannin-Reduced Graphene Oxide-PtPd Nanocomposites
por: Li, Guiyin, et al.
Publicado: (2023)

The Degree of Hyperglycemia Excursion in Patients of Kidney Transplantation (KT) or Liver Transplantation (LT) Assessed by Continuous Glucose Monitoring (CGM): Pilot Study
por: Jin, Heung Yong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_scjh5inlvhaos8mmd6gjdjgpfk